What does patent strategy really look like inside a large, innovation-driven corporation?
In this episode of Patent Matters, hosts Mie Rasmussen and Dave Hunt go inside the corporate IP function with Lars Balzer Nielsen, a veteran patent leader with 25 years of experience shaping patent strategy in the diabetes and obesity care industry.
Drawing on his background as a former patent examiner, European patent attorney, and PhD in chemical engineering, Lars shares a rare, candid perspective on how large companies make real-world IP decisions — far beyond theory and checklists.
Together, they explore:
- How patent strategy should support business strategy — not exist on its own
- When to patent vs. keep innovations as trade secrets
- How companies decide where to file patents under budget and uncertainty
- Managing long product life cycles, evolving portfolios, and freedom-to-operate risks
- Building strong, cross-functional IP teams across science, legal, and business
- Preparing for litigation, competition, and the unexpected
- What startups and universities should consider when building early patent portfolios
Lars also shares five hard-earned principles for managing corporate IP teams — from relationship-building and long-term thinking to clear communication and courageous decision-making.
Whether you work inside a corporation, advise innovative companies, or are simply curious about how major players protect and defend innovation, this episode offers an inside look you won’t want to miss.